Zimmerer J M, Pham T A, Wright C L, Tobin K J, Sanghavi P B, Elzein S M, Sanders V M, Bumgardner G L
Department of Surgery, Comprehensive Transplant Center, The Ohio State University Wexner Medical Center, Columbus, OH.
Am J Transplant. 2014 Feb;14(2):295-304. doi: 10.1111/ajt.12565.
While it is well known that CD4(+) T cells and B cells collaborate for antibody production, our group previously reported that CD8(+) T cells down-regulate alloantibody responses following transplantation. However, the exact mechanism involved in CD8(+) T cell-mediated down-regulation of alloantibody remains unclear. We also reported that alloantibody production is enhanced when either perforin or FasL is deficient in transplant recipients. Here, we report that CD8(+) T cell-deficient transplant recipient mice (high alloantibody producers) exhibit an increased number of primed B cells compared to WT transplant recipients. Furthermore, CD8(+) T cells require FasL, perforin and allospecificity to down-regulate posttransplant alloantibody production. In vivo CD8-mediated clearance of alloprimed B cells was also FasL- and perforin-dependent. In vitro data demonstrated that recipient CD8(+) T cells directly induce apoptosis of alloprimed IgG1(+) B cells in co-culture in an allospecific and MHC class I-dependent fashion. Altogether these data are consistent with the interpretation that CD8(+) T cells down-regulate posttransplant alloantibody production by FasL- and perforin-dependent direct elimination of alloprimed IgG1(+) B cells.
虽然众所周知CD4(+) T细胞和B细胞协作产生抗体,但我们的研究小组此前报道,CD8(+) T细胞在移植后会下调同种异体抗体反应。然而,CD8(+) T细胞介导的同种异体抗体下调的确切机制仍不清楚。我们还报道,当移植受者的穿孔素或FasL缺陷时,同种异体抗体的产生会增强。在此,我们报告,与野生型移植受者相比,CD8(+) T细胞缺陷的移植受者小鼠(高同种异体抗体产生者)的致敏B细胞数量增加。此外,CD8(+) T细胞需要FasL、穿孔素和同种特异性来下调移植后的同种异体抗体产生。体内CD8介导的同种致敏B细胞清除也依赖于FasL和穿孔素。体外数据表明,受体CD8(+) T细胞在共培养中以同种特异性和MHC I类依赖性方式直接诱导同种致敏IgG1(+) B细胞凋亡。总之,这些数据与以下解释一致:CD8(+) T细胞通过FasL和穿孔素依赖性直接清除同种致敏IgG1(+) B细胞来下调移植后的同种异体抗体产生。